Sinovac biotech ltd (SVA)
CashFlow / Yearly
Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows provided by (used in) operating activities
Income (loss) from continuing operations

36,705

-3,058

-229

279

11,636

-

-

-

-

Net income (loss)

-

-

-

-

-

-18,749

-399

-12,602

30,413

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
- Deferred income taxes (note 13)

-4,921

-1,007

-333

-225

-2,225

-17

2,845

-1,708

1,261

- Share-based compensation (note 18)

979

2,409

952

287

281

347

206

459

422

- Inventory provision (note 6)

1,231

6,377

1,820

1,026

1,052

3,479

4,034

6,805

593

- Provision (recovery) for doubtful accounts

934

1,412

-49

329

-504

-874

-167

1,921

-

Loss on disposal of property, plant and equipment (note 8)

-42

-478

-26

-

-

-

-

-

-

- Loss on disposal and impairment of property, plant and equipment (note 9)

-

-

-

-74

-88

-2,190

-455

-1,237

-

- Research and development expenditures qualified for government grant

-

-

-

-

-

125

686

43

-

- Depreciation of property, plant and equipment and amortization of licenses (note 8)

4,638

5,063

6,258

7,837

6,097

4,189

4,540

-

-

- Amortization of prepaid land lease payments (note 9)

243

247

261

267

311

299

285

-

-

- Government grants recognized in income

141

6,984

1,637

104

0

-

-

-

-

- provision for (recovery of) doubtful accounts

-

-

-

-

-

-

-

-

17

- write-down of equipment and loss on disposal

-

-

-

-

-

-

-

-

-169

- research and development expenditures qualified for government grant

-

-

-

-

-

-

-

-

251

- depreciation of property, plant and equipment and amortization of licenses and permits

-

-

-

-

-

-

-

4,232

2,239

- Deferred government grant recognized in income

-

-

-

-

-

-358

-434

-416

-1,119

- Accretion expenses

0

0

120

114

100

235

377

117

-

Changes in:
- Accounts receivable

13,482

15,122

-41

9,691

7,256

4,286

-5,475

-1,003

5,019

- Inventories

5,531

3,025

-28

6,130

7,157

426

1,915

8,597

5,384

- Income tax payable

4,948

1,720

576

899

7

-3,130

1,340

-5,524

6,758

- Prepaid expenses and deposits

622

436

-434

506

-243

-913

531

903

-468

- Deferred revenue

987

-4,959

-3,639

601

-675

1,026

-2,696

426

12,722

- Accounts payable and accrued liabilities

33,416

2,739

-298

-3,493

4,450

-967

1,208

-686

5,118

- Other non-current liabilities

330

339

779

932

0

-

-

-

-

- Restricted cash

-1,598

1,557

1,677

0

0

-

-

-

-

- Time deposits

0

0

-1,500

1,500

-

-

-

-

-

Net cash provided by (used in) operating activities from continuing operations

61,354

-15,364

4,933

-9,004

6,448

-16,254

13,936

-14,278

48,411

Net cash used in operating activities from discontinued operations

0

-95

-722

-1,123

-872

-

-

-

-

Net cash provided by (used in) operating activities

61,354

-15,459

4,211

-10,127

5,576

-

-

-

-

Cash flows provided by (used in) financing activities
- Proceeds from bank loans

28,636

45,462

21,312

17,837

16,800

16,787

11,392

-

-

- Repayments of bank loans

38,708

24,850

46,786

15,962

4,089

4,755

10,659

-

-

- Loan proceeds

-

-

-

-

-

-

-

19,989

17,687

- Loan repayments

-

-

-

-

-

-

-

17,850

10,232

- Proceeds from issuance of common stock, net of share issuance costs

1,264

315

732

512

814

508

749

62,255

697

- Proceeds from shares subscribed

428

0

18

51

18

8

3

-

-

- Dividends paid to a non-controlling shareholder

-

-

-

-

-

802

5,863

-

-

- Repurchase of common shares

-

-

-

-

-

-

-

-

335

- Proceeds from shares subscribed

-

-

-

-

-

-

-

-

4

- Dividends paid to non-controlling shareholder of Sinovac Beijing

-

-

-

-

-

-

-

3,285

3,846

- Government grants received (note 15)

2,598

6,857

544

3,520

842

2,395

1,593

372

1,318

- Loan from a non-controlling shareholder (note 11(a))

4,440

0

0

-

-

-

-

-

-

- Repayment of loan from a non-controlling shareholder

0

0

-16

-649

0

-

3,398

-3,286

-

- Proceeds of loan from a non-controlling shareholder

-

-

-

-

-

3,189

-

-

-

Net cash provided by (used in) financing activities from continuing operations

-

-

-

-

14,385

17,330

613

58,193

5,292

Net cash provided by financing activities from discontinued operations

-

-

-

-

34

-

-

-

-

Net cash provided by (used in) financing activities

-1,342

27,784

-24,196

5,309

14,419

-

-

-

-

Cash flows used in investing activities
- Restricted cash

-

-

-

-

-

-

-

-64

64

- Proceeds from disposal of equipment

19

26

81

0

0

5

122

231

-

- Proceeds from redemption of short-term investments

-

-

-

-

-

-

1,545

7,314

-

- Purchase of short-term investments

-

-

-

-

-

-

-

1,475

7,308

- Prepayments for acquisition of equipment

-

-

-

-

-

-

-

562

-

- Acquisition of property, plant and equipment

11,915

12,654

5,299

10,913

5,133

16,156

15,457

24,817

4,320

- Net proceeds from disposal of subsidiary

0

861

801

0

0

-

-

-

-

Net cash used in investing activities from continuing operations

-11,896

-11,767

-4,417

-10,913

-5,133

-16,151

-13,790

-19,244

-11,693

Net cash used in investing activities from discontinued operations

0

-9

-98

-90

-43

-

-

-

-

Net cash used in investing activities

-11,896

-11,776

-4,515

-11,003

-5,176

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents, including cash classified within current assets held for sale

3,865

-2,092

-1,541

-1,403

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents, including cash classified within current assets held for sale

-

-

-

-

1,182

2,029

1,943

1,961

48

Increase (decrease) in cash and cash equivalents, including cash classified within current assets held for sale

-

-

-

-

16,001

-

-

-

-

Less: Net increase (decrease) in cash classified within current assets assets for sale

-

-

-

-

-703

-

-

-

-

Increase (decrease) in cash and cash equivalents, including cash from discontinued operation

51,981

-1,543

-26,041

-17,224

15,298

-13,046

2,702

26,632

-

Less: Net decrease in cash from discontinued operation

0

-143

-82

-500

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

51,981

-1,400

-25,959

-16,724

-

-

-

-

-

Increase in cash and cash equivalents

-

-

-

-

-

-

-

-

42,059

Supplemental disclosure of cash flow information:
Cash paid for interest

1,325

1,662

1,722

3,152

2,853

750

456

1,017

-

Cash paid for interest, net of amount capitalized

-

-

-

-

-

-

-

-

914

Cash paid for income taxes

7,909

1,885

2,058

491

0

2,265

882

5,986

3,066

Acquisition of property, plant and equipment included in accounts payable and accrued liabilities

-

-

-

-

2,015

3,788

9,125

3,958

1,120